Sarah Pennington

Sarah Pennington
Biography
Sarah Pennington advises clients on matters in all areas of intellectual property law, including patents, trademarks, copyright, and domain name disputes. Her practice also spans a range of industries, including the pharmaceutical, life sciences, technology, food and beverage, fashion, healthcare, and consumer product sectors.
As a litigator, Sarah provides strategic legal counsel and representation to businesses and individuals faced with litigation or potential litigation. Sarah has acted for clients in complex litigation and administrative proceedings at all levels of the Federal Court.
Sarah's advisory work focusses on providing strategic guidance to companies regulated by both federal and provincial bodies, primarily in the life sciences and healthcare industry. She helps clients navigate complicated regulatory landscapes implemented through legislation - including the Food and Drugs Act and its Regulations - and available guidance. Her regulatory practice routinely involves a variety of issues, including advertising, drug approval pathways, pricing, licensing, reimbursement, data protection, Patent Register listings, and access to information.
Sarah joined our Toronto office as a summer student in 2017 and returned to article with us in 2018-2019. During law school, Sarah developed practical advocacy skills working as a summer student for a leading civil litigation and insurance law firm.
Sarah is a frequent author for the firm's Pharma in Brief bulletin.
Professional experience
Rankings and recognitions
Rankings and recognitions
- Best Lawyers: Ones to Watch in Canada: Intellectual Property Law, 2024-2026
Education
Education
- J.D., Osgoode Hall Law School, 2018
- B.A. (Hons.), History and English, University of Windsor, 2015
Admissions
Admissions
- Ontario 2019
Publications
Publications
- Pharma in Brief - National Pharmacare: Canada’s Drug Agency Consulting on National Bulk Purchasing Strategy, July 2025
- Pharma in Brief - National Pharmacare: Canada’s Drug Agency Consulting on List of Essential Prescription Drugs, June 2025
- Pharma in Brief - Canada expanding national pharmacare and rare disease drug coverage, March 2025
- Pharma in Brief - Agile licensing, risk, biologics, and more: Wide-ranging amendments to Canada’s drug and medical device regulations, March 2025
- Pharma in Brief - National pharmacare in Canada: First-ever funding agreement announced, February 2025
- Pharma in Brief - Recent developments in Canadian national pharmacare and funding for drugs for rare diseases, December 2024
- Pharma in Brief - Pharmacare Act becomes law in Canada, October 2024
- Pharma in Brief - Pharmacare: BC first to announce partnership with federal government, September 2024
- Pharma in Brief - CADTH to Transform into Canada’s Drug Agency, May 2024
- Pharma in Brief - Drug price negotiations: pCPA Temporary Access Process launched, April 2024
Memberships and activities
Memberships and activities
- Ontario Bar Association
- Toronto Intellectual Property Group
- Intellectual Property Institute of Canada
Languages
Languages
- English